Two Abstracts Highlighting the Endocrine Activity Index were Presented at the 2024 Annual Society of Clinical Oncology Meeting
Press Release Two Abstracts Highlighting the Endocrine Activity Index were Presented at the 2024 Annual Society of Clinical Oncology Meeting Abstracts highlighting the value of the Endocrine Activity Index were presented at ASCO 2024. The first abstract (538) highlighted the prognostic value for patients with Stage II-III breast cancer. The second abstract (565) highlighted the […]
New Data Confirms Endocrine Activity Index® as a Predictor of Benefit from Dose-Dense Chemotherapy
Press Release New Data Confirms Endocrine Activity Index as a Predictor of Benefit from Dose-Dense Chemotherapy Data from the GEICAM/9906 trial, presented at the San Antonio Breast Cancer Symposium (SABCS) in December 2024, provides independent confirmation of the predictive value of the Endocrine Activity Index (EAITM).1 In addition, results from a 12-year outcomes analysis from the […]
Delphi Diagnostics® Inc. Announces a Strategic Partnership with Protean BioDiagostics to Offer the Endocrine Activity Index
Press Release Delphi Diagnostics® Inc. Announces a Strategic Partnership with Protean BioDiagostics to Offer the Endocrine Activity Index Working collaboratively with Protean BioDiagnostics, Inc. to offer the Endocrine Activity IndexTM (EAITM) will allow Delphi Diagnostics to expand the ability to participate in additional clinical trials, as well as begin an Early Access Program in the first […]